These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 17267745

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Holdsworth SR.
    J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
    Phoon RK, Kitching AR, Jones LK, Holdsworth SR.
    Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte macrophage colony-stimulating factor expression by both renal parenchymal and immune cells mediates murine crescentic glomerulonephritis.
    Timoshanko JR, Kitching AR, Semple TJ, Holdsworth SR, Tipping PG.
    J Am Soc Nephrol; 2005 Sep; 16(9):2646-56. PubMed ID: 16033860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
    Odobasic D, Kitching AR, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR.
    J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody.
    Nagao T, Matsumura M, Mabuchi A, Ishida-Okawara A, Koshio O, Nakayama T, Minamitani H, Suzuki K.
    Nephrol Dial Transplant; 2007 Jan; 22(1):77-87. PubMed ID: 17005520
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neutrophil contribution to the crescentic glomerulonephritis in SCG/Kj mice.
    Ishida-Okawara A, Ito-Ihara T, Muso E, Ono T, Saiga K, Nemoto K, Suzuki K.
    Nephrol Dial Transplant; 2004 Jul; 19(7):1708-15. PubMed ID: 15150352
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
    Schreiber A, Xiao H, Falk RJ, Jennette JC.
    J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice.
    Haas C, Ryffel B, Le Hir M.
    J Inflamm; 2006 Dec; 47(4):206-13. PubMed ID: 9144077
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
    Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR.
    Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
    [Abstract] [Full Text] [Related]

  • 20. Morphologic correlates of glomerular oxidant injury induced by the myeloperoxidase-hydrogen peroxide-halide system of the neutrophil.
    Johnson RJ, Guggenheim SJ, Klebanoff SJ, Ochi RF, Wass A, Baker P, Schulze M, Couser WG.
    Lab Invest; 1988 Mar; 58(3):294-301. PubMed ID: 2831432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.